Literature DB >> 938266

Neuroelectric blocking factors in multiple sclerosis and normal human sera.

F J Seil, A L Leiman, J M Kelly.   

Abstract

Serum samples from 13 multiple sclerosis (MS) patients and ten normal human serum samples were applied to cerebral neocortex cultures and evaluated for their ability to block evoked electric activity. A high proportion of sera positive for neuroelectric blocking factors was found in both groups, and there was no substantial difference between serum samples from MS patients and those from normal human volunteers. Some of the neuroelectric blocking factors were thermolabile, others were thermostable, and still others may have been complement-dependent. It is concluded that the ability to block evoked electric responses in tissue cultures is a nonspecific serum property, and that it is not specifically related to the pathogenesis of demyelinating disease.

Entities:  

Mesh:

Year:  1976        PMID: 938266     DOI: 10.1001/archneur.1976.00500060024006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord.

Authors:  C L Schauf; F A Davis; D A Sack; B J Reed; R L Kesler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-07       Impact factor: 10.154

2.  The role of myo-inositol in multiple sclerosis.

Authors:  G B Young; W J Hader; M Hiscock; K G Warren; D Logan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

Review 3.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

4.  Multiple sclerosis: demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological diseases.

Authors:  J Ulrich; H Lardi
Journal:  J Neurol       Date:  1978-04-14       Impact factor: 4.849

5.  Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.

Authors:  Christina Elliott; Maren Lindner; Ariel Arthur; Kathryn Brennan; Sven Jarius; John Hussey; Andrew Chan; Anke Stroet; Tomas Olsson; Hugh Willison; Susan C Barnett; Edgar Meinl; Christopher Linington
Journal:  Brain       Date:  2012-05-04       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.